At the White House Tuesday evening, Health and Human Services Secretary Robert F. Kennedy Jr. said that President Trump had signed an executive order that will rein in pharmaceutical advertising on television and other media.
According to Kennedy, federal regulations dating back to 1997 will be restored, forcing pharmaceutical companies to clearly disclose all side effects associated with their drugs on all broadcast ads.
Kennedy explained that in 1997 pharmaceutical companies lobbied to remove the ‘full disclosure’ requirement because it lengthened ads, forcing companies to shell out more money.